681809-18-7Relevant academic research and scientific papers
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 109, (2010/02/11)
Hepatitis C virus inhibitors are disclosed having the general formula (I) wherein A, R2, R3, R', B and Y are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Substituted cycloalkyl P1' hepatitis C virus inhibitors
-
Page/Page column 111, (2010/02/06)
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
